CHICAGO--(BUSINESS WIRE)--Chicago-based emerging medical device firm Advanced Cooling Therapy (ACT) has closed a $1.5 million Series A financing round to support the full commercial launch of its first product, the Esophageal
Investors include Heartland Angels, Gopher Angels and TWB Investment Partnership along with several individual investors.
The ECD is a single use, fully-enclosed triple lumen system that is inserted into the esophagus to modulate and control patient temperature when clinically indicated. Two lumens attach to existing temperature modulation equipment while a third lumen simultaneously allows gastric decompression and drainage
Hey, check out all the research scientist jobs. Post your resume today!